Mast cell activation syndromes
Annals of Allergy, Asthma & Immunology
July 2013 Volume 111, Issue 1, Pages 5-8
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices.
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Committee Members:
Cem Akin, MD, PhD (Author)
Michael S. Tankersley, MD (CME Series Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
- Describe the classification of mast cell activation disorders with emphasis on monoclonal mast cell activation syndrome (MMAS) and idiopathic mast cell activation syndrome (MCAS)
- Discuss the clinical presentations, evaluation, diagnostic approach and management of MMAS and MCAS disorders
Min Jung Lee, MD; and Cem Akin, MD, PhD
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
- 1.00 MOC